Health Advance Inc. (HADV)
USD 0.0
(-14.29%)
USD 0.0
(-14.29%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | -47.57 Thousand USD | 82.14% |
| 2023 | -266.34 Thousand USD | -110.85% |
| 2022 | -126.31 Thousand USD | -476.01% |
| 2021 | -21.93 Thousand USD | 0.0% |
| 2016 | -29.5 Thousand USD | 56.16% |
| 2015 | -67.3 Thousand USD | 6.36% |
| 2014 | -71.87 Thousand USD | 16.1% |
| 2013 | -85.66 Thousand USD | 21.56% |
| 2012 | -109.21 Thousand USD | -60.83% |
| 2011 | -67.9 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 FY | -47.57 Thousand USD | 82.14% |
| 2024 Q3 | -10.94 Thousand USD | 0.64% |
| 2024 Q2 | -11.01 Thousand USD | 28.27% |
| 2024 Q1 | -15.35 Thousand USD | -49.46% |
| 2023 Q3 | -20.44 Thousand USD | 84.9% |
| 2023 Q4 | -10.27 Thousand USD | 49.76% |
| 2023 Q2 | -135.36 Thousand USD | -416.25% |
| 2023 FY | -266.34 Thousand USD | -110.85% |
| 2023 Q1 | -26.22 Thousand USD | 0.0% |
| 2022 FY | -126.31 Thousand USD | -476.01% |
| 2022 Q4 | -26.22 Thousand USD | 0.0% |
| 2021 FY | -21.93 Thousand USD | 0.0% |
| 2017 Q1 | -9460.00 USD | 14.91% |
| 2017 Q3 | -74.28 Thousand USD | 0.0% |
| 2016 Q1 | -6076.00 USD | 49.83% |
| 2016 Q3 | -6769.00 USD | -38.74% |
| 2016 Q2 | -4879.00 USD | 19.7% |
| 2016 FY | -29.5 Thousand USD | 56.16% |
| 2016 Q4 | -11.11 Thousand USD | -64.23% |
| 2015 FY | -67.3 Thousand USD | 6.36% |
| 2015 Q4 | -12.11 Thousand USD | -88.19% |
| 2015 Q3 | -6436.00 USD | -0.91% |
| 2015 Q2 | -6378.00 USD | 60.58% |
| 2015 Q1 | -16.17 Thousand USD | 22.76% |
| 2014 Q2 | -19.04 Thousand USD | -11.56% |
| 2014 Q1 | -17.07 Thousand USD | -2.99% |
| 2014 Q4 | -20.94 Thousand USD | 11.98% |
| 2014 FY | -71.87 Thousand USD | 16.1% |
| 2014 Q3 | -23.79 Thousand USD | -24.95% |
| 2013 Q3 | -19.17 Thousand USD | 18.23% |
| 2013 Q2 | -23.45 Thousand USD | 33.89% |
| 2013 Q1 | -35.47 Thousand USD | -0.47% |
| 2013 FY | -85.66 Thousand USD | 21.56% |
| 2013 Q4 | -16.57 Thousand USD | 13.55% |
| 2012 FY | -109.21 Thousand USD | -60.83% |
| 2012 Q2 | -28.72 Thousand USD | -45.09% |
| 2012 Q1 | -19.79 Thousand USD | 42.14% |
| 2012 Q4 | -35.3 Thousand USD | -217.97% |
| 2012 Q3 | -11.1 Thousand USD | 61.34% |
| 2011 FY | -67.9 Thousand USD | 0.0% |
| 2011 Q3 | -26.47 Thousand USD | 0.0% |
| 2011 Q4 | -34.21 Thousand USD | -29.24% |
| 2010 Q4 | - USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Alternative Energy Partners, Inc. | -261.11 USD | -18118.375% |
| Allstar Health Brands, Inc. | -215.75 Thousand USD | 77.951% |
| Beijing Tong Ren Tang Chinese Medicine Company Limited | 624.14 Million USD | 100.008% |
| Café Serendipity Holdings, Inc. | -1.43 Million USD | 96.685% |
| Decision Diagnostics Corp. | - USD | Infinity% |
| HealthWarehouse.com, Inc. | -1.62 Million USD | 97.067% |
| LIGAND PHARMACEUTICAL INC | 9.82 Million USD | 100.484% |
| MedGen, Inc. | -15.54 USD | -306013.256% |
| Omni Health, Inc. | 405.52 Thousand USD | 111.731% |
| Oxford Investments Holdings Inc. | -342.3 Thousand USD | 86.103% |
| Pineapple, Inc. | -1.47 Million USD | 96.781% |
| ScripsAmerica, Inc. | -3.8 Million USD | 98.751% |